AKT1 and rheumatoid arthritis: Mechanistically, the piENOX2 inhibitor stabilized ALKBH5 expression, reducing Itga4 m6A modifications, sustaining PI3K–AKT pathway activation and thereby promoted macrophage M2 polarization and slowed the progression of RA.